APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Papaverine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Papaverine Injection Industry Growth and Trends Forecast to 2032

Report ID 174022180120 December 2025113 pages

Choose your research edition.

Industry ResearchPapaverine Injection Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Papaverine Injection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Papaverine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Papaverine Injection Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Papaverine Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Papaverine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Papaverine Injection include Sandoz, Pude Pharma, Changjiang Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Hunan Yige Pharmaceutical, Furen Pharmaceutical, Northeast Pharmaceutical Group, Chengdu Brilliant Pharmaceutical and Vulcan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Papaverine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Papaverine Injection market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Papaverine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Papaverine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Papaverine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Papaverine Injection Market by Company

Sandoz

Pude Pharma

Changjiang Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Hunan Yige Pharmaceutical

Furen Pharmaceutical

Northeast Pharmaceutical Group

Chengdu Brilliant Pharmaceutical

Vulcan

SGPharma

Oryza Pharmaceuticals

Montage Laboratories

Mercury Laboratories

Cipla

Centurion Healthcare

American Regent

Papaverine Injection Segment by Type

30mg

60mg

Papaverine Injection Segment by Application

Vascular Disease

Gastrointestinal and Biliary Spasms

Papaverine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Papaverine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Papaverine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Papaverine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Papaverine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Papaverine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 30mg Table 2. Major Company of 60mg Table 3. Global Papaverine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Papaverine Injection Sales by Type (2021-2026) & (L) Table 5. Global Papaverine Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Papaverine Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Papaverine Injection Price by Type (2021-2026) & (US$/ml) Table 9. Global Papaverine Injection Sales by Type (2027-2032) & (L) Table 10. Global Papaverine Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Papaverine Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Papaverine Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Papaverine Injection Price by Type (2027-2032) & (US$/ml) Table 14. North America Papaverine Injection Sales by Type (2021-2026) & (L) Table 15. North America Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Papaverine Injection Sales by Type (2021-2026) & (L) Table 17. Europe Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Papaverine Injection Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Papaverine Injection Sales by Type (2021-2026) & (L) Table 21. Latin America Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Papaverine Injection Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa Papaverine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Papaverine Injection Industry Trends Table 25. Papaverine Injection Industry Drivers Table 26. Papaverine Injection Industry Opportunities and Challenges Table 27. Papaverine Injection Industry Restraints Table 28. Global Papaverine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Papaverine Injection Revenue Market Share by Company (2021-2026) Table 30. Global Papaverine Injection Sales by Company (2021-2026) & (L) Table 31. Global Papaverine Injection Sales Share by Company (2021-2026) Table 32. Global Papaverine Injection Market Price by Company (2021-2026) & (US$/ml) Table 33. Global Papaverine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Papaverine Injection Major Company Production Sites and Headquarters Table 35. Global Papaverine Injection Company, Product Type & Application Table 36. Global Papaverine Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Papaverine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Papaverine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Papaverine Injection Sales by Region (2021-2026) & (L) Table 41. Global Papaverine Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Papaverine Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Papaverine Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Papaverine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 45. Global Papaverine Injection Sales by Region (2027-2032) & (L) Table 46. Global Papaverine Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Papaverine Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Papaverine Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Papaverine Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 50. Global Papaverine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Papaverine Injection Sales by Application (2021-2026) & (L) Table 52. Global Papaverine Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Papaverine Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Papaverine Injection Price by Application (2021-2026) & (US$/ml) Table 56. Global Papaverine Injection Sales by Application (2027-2032) & (L) Table 57. Global Papaverine Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Papaverine Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Papaverine Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Papaverine Injection Price by Application (2027-2032) & (US$/ml) Table 61. North America Papaverine Injection Sales by Application (2021-2026) & (L) Table 62. North America Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Papaverine Injection Sales by Application (2021-2026) & (L) Table 64. Europe Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Papaverine Injection Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Papaverine Injection Sales by Application (2021-2026) & (L) Table 68. Latin America Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Papaverine Injection Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa Papaverine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Sandoz Company Information Table 72. Sandoz Business Overview Table 73. Sandoz Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 74. Sandoz Papaverine Injection Product Portfolio Table 75. Sandoz Recent Development Table 76. Pude Pharma Company Information Table 77. Pude Pharma Business Overview Table 78. Pude Pharma Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 79. Pude Pharma Papaverine Injection Product Portfolio Table 80. Pude Pharma Recent Development Table 81. Changjiang Pharmaceutical Company Information Table 82. Changjiang Pharmaceutical Business Overview Table 83. Changjiang Pharmaceutical Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 84. Changjiang Pharmaceutical Papaverine Injection Product Portfolio Table 85. Changjiang Pharmaceutical Recent Development Table 86. Jiangsu Hengrui Pharmaceuticals Company Information Table 87. Jiangsu Hengrui Pharmaceuticals Business Overview Table 88. Jiangsu Hengrui Pharmaceuticals Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 89. Jiangsu Hengrui Pharmaceuticals Papaverine Injection Product Portfolio Table 90. Jiangsu Hengrui Pharmaceuticals Recent Development Table 91. Hunan Yige Pharmaceutical Company Information Table 92. Hunan Yige Pharmaceutical Business Overview Table 93. Hunan Yige Pharmaceutical Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 94. Hunan Yige Pharmaceutical Papaverine Injection Product Portfolio Table 95. Hunan Yige Pharmaceutical Recent Development Table 96. Furen Pharmaceutical Company Information Table 97. Furen Pharmaceutical Business Overview Table 98. Furen Pharmaceutical Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 99. Furen Pharmaceutical Papaverine Injection Product Portfolio Table 100. Furen Pharmaceutical Recent Development Table 101. Northeast Pharmaceutical Group Company Information Table 102. Northeast Pharmaceutical Group Business Overview Table 103. Northeast Pharmaceutical Group Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 104. Northeast Pharmaceutical Group Papaverine Injection Product Portfolio Table 105. Northeast Pharmaceutical Group Recent Development Table 106. Chengdu Brilliant Pharmaceutical Company Information Table 107. Chengdu Brilliant Pharmaceutical Business Overview Table 108. Chengdu Brilliant Pharmaceutical Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 109. Chengdu Brilliant Pharmaceutical Papaverine Injection Product Portfolio Table 110. Chengdu Brilliant Pharmaceutical Recent Development Table 111. Vulcan Company Information Table 112. Vulcan Business Overview Table 113. Vulcan Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 114. Vulcan Papaverine Injection Product Portfolio Table 115. Vulcan Recent Development Table 116. SGPharma Company Information Table 117. SGPharma Business Overview Table 118. SGPharma Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 119. SGPharma Papaverine Injection Product Portfolio Table 120. SGPharma Recent Development Table 121. Oryza Pharmaceuticals Company Information Table 122. Oryza Pharmaceuticals Business Overview Table 123. Oryza Pharmaceuticals Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 124. Oryza Pharmaceuticals Papaverine Injection Product Portfolio Table 125. Oryza Pharmaceuticals Recent Development Table 126. Montage Laboratories Company Information Table 127. Montage Laboratories Business Overview Table 128. Montage Laboratories Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 129. Montage Laboratories Papaverine Injection Product Portfolio Table 130. Montage Laboratories Recent Development Table 131. Mercury Laboratories Company Information Table 132. Mercury Laboratories Business Overview Table 133. Mercury Laboratories Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 134. Mercury Laboratories Papaverine Injection Product Portfolio Table 135. Mercury Laboratories Recent Development Table 136. Cipla Company Information Table 137. Cipla Business Overview Table 138. Cipla Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 139. Cipla Papaverine Injection Product Portfolio Table 140. Cipla Recent Development Table 141. Centurion Healthcare Company Information Table 142. Centurion Healthcare Business Overview Table 143. Centurion Healthcare Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 144. Centurion Healthcare Papaverine Injection Product Portfolio Table 145. Centurion Healthcare Recent Development Table 146. American Regent Company Information Table 147. American Regent Business Overview Table 148. American Regent Papaverine Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 149. American Regent Papaverine Injection Product Portfolio Table 150. American Regent Recent Development Table 151. North America Papaverine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 152. North America Papaverine Injection Sales by Country (2021-2026) & (L) Table 153. North America Papaverine Injection Sales Market Share by Country (2021-2026) Table 154. North America Papaverine Injection Sales Forecast by Country (2027-2032) & (L) Table 155. North America Papaverine Injection Sales Market Share Forecast by Country (2027-2032) Table 156. North America Papaverine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Papaverine Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Papaverine Injection Market Share by Country (2021-2026) Table 159. North America Papaverine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Papaverine Injection Market Share Forecast by Country (2027-2032) Table 161. Europe Papaverine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 162. Europe Papaverine Injection Sales by Country (2021-2026) & (L) Table 163. Europe Papaverine Injection Sales Market Share by Country (2021-2026) Table 164. Europe Papaverine Injection Sales Forecast by Country (2027-2032) & (L) Table 165. Europe Papaverine Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Papaverine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Papaverine Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Papaverine Injection Market Share by Country (2021-2026) Table 169. Europe Papaverine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Papaverine Injection Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Papaverine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Papaverine Injection Sales by Country (2021-2026) & (L) Table 173. Asia-Pacific Papaverine Injection Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Papaverine Injection Sales Forecast by Country (2027-2032) & (L) Table 175. Asia-Pacific Papaverine Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Papaverine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Papaverine Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Papaverine Injection Market Share by Country (2021-2026) Table 179. Asia-Pacific Papaverine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Papaverine Injection Market Share Forecast by Country (2027-2032) Table 181. Latin America Papaverine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 182. Latin America Papaverine Injection Sales by Country (2021-2026) & (L) Table 183. Latin America Papaverine Injection Sales Market Share by Country (2021-2026) Table 184. Latin America Papaverine Injection Sales Forecast by Country (2027-2032) & (L) Table 185. Latin America Papaverine Injection Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Papaverine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Papaverine Injection Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Papaverine Injection Market Share by Country (2021-2026) Table 189. Latin America Papaverine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Papaverine Injection Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Papaverine Injection Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Papaverine Injection Sales by Country (2021-2026) & (L) Table 193. Middle East and Africa Papaverine Injection Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Papaverine Injection Sales Forecast by Country (2027-2032) & (L) Table 195. Middle East and Africa Papaverine Injection Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Papaverine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Papaverine Injection Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Papaverine Injection Market Share by Country (2021-2026) Table 199. Middle East and Africa Papaverine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Papaverine Injection Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Papaverine Injection Distributors List Table 204. Papaverine Injection Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Papaverine Injection Image Figure 2. Global Papaverine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Papaverine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Papaverine Injection Sales (2021-2032) & (L) Figure 5. 30mg Image Figure 6. Global 30mg Sales YoY Growth (2021-2032) & (L) Figure 7. 60mg Image Figure 8. Global 60mg Sales YoY Growth (2021-2032) & (L) Figure 9. Global Papaverine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Papaverine Injection Market Share by Type 2025 VS 2032 Figure 11. North America Papaverine Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Papaverine Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Papaverine Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Papaverine Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Papaverine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Papaverine Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Papaverine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Papaverine Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Papaverine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Papaverine Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Papaverine Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Vascular Disease Image Figure 24. Global Vascular Disease Sales YoY Growth (2021-2032) & (L) Figure 25. Gastrointestinal and Biliary Spasms Image Figure 26. Global Gastrointestinal and Biliary Spasms Sales YoY Growth (2021-2032) & (L) Figure 27. Global Papaverine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Papaverine Injection Market Share by Application 2025 VS 2032 Figure 29. North America Papaverine Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Papaverine Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Papaverine Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Papaverine Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Papaverine Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Papaverine Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Papaverine Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Papaverine Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Papaverine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Papaverine Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Papaverine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America Papaverine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Papaverine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Papaverine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Papaverine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe Papaverine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Papaverine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Papaverine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Papaverine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific Papaverine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Papaverine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Papaverine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Papaverine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America Papaverine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Papaverine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Papaverine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Papaverine Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa Papaverine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Papaverine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Papaverine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Papaverine Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Papaverine Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
Applications
  • Vascular Disease
  • Gastrointestinal and Biliary Spasms
Companies covered
  • Sandoz
  • Pude Pharma
  • Changjiang Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Hunan Yige Pharmaceutical
  • Furen Pharmaceutical
  • Northeast Pharmaceutical Group
  • Chengdu Brilliant Pharmaceutical
  • Vulcan
  • SGPharma
  • Oryza Pharmaceuticals
  • Montage Laboratories
  • Mercury Laboratories
  • Cipla
  • Centurion Healthcare
  • American Regent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Papaverine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Papaverine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Papaverine Injection Market by Type
  6. 1.3.1 30mg
  7. 1.3.2 60mg
  8. 1.4 Global Papaverine Injection Market Size by Type
  9. 1.4.1 Global Papaverine Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Papaverine Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Papaverine Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Papaverine Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Papaverine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Papaverine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Papaverine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Papaverine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Papaverine Injection Industry Trends
  2. 2.2 Papaverine Injection Industry Drivers
  3. 2.3 Papaverine Injection Industry Opportunities and Challenges
  4. 2.4 Papaverine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Papaverine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Papaverine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Papaverine Injection Price (2021-2026)
  4. 3.4 Global Papaverine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Papaverine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Papaverine Injection Company, Product Type & Application
  7. 3.7 Global Papaverine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Papaverine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Papaverine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Papaverine Injection Tier 1, Tier 2, and Tier 3
4 Papaverine Injection Regional Status and Outlook
  1. 4.1 Global Papaverine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Papaverine Injection Historic Market Size by Region
  3. 4.2.1 Global Papaverine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Papaverine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Papaverine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Papaverine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Papaverine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Papaverine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Papaverine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Papaverine Injection by Application
  1. 5.1 Papaverine Injection Market by Application
  2. 5.1.1 Vascular Disease
  3. 5.1.2 Gastrointestinal and Biliary Spasms
  4. 5.2 Global Papaverine Injection Market Size by Application
  5. 5.2.1 Global Papaverine Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Papaverine Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Papaverine Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Papaverine Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Papaverine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Papaverine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Papaverine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Papaverine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sandoz
  2. 6.1.1 Sandoz Company Information
  3. 6.1.2 Sandoz Business Overview
  4. 6.1.3 Sandoz Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sandoz Papaverine Injection Product Portfolio
  6. 6.1.5 Sandoz Recent Developments
  7. 6.2 Pude Pharma
  8. 6.2.1 Pude Pharma Company Information
  9. 6.2.2 Pude Pharma Business Overview
  10. 6.2.3 Pude Pharma Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pude Pharma Papaverine Injection Product Portfolio
  12. 6.2.5 Pude Pharma Recent Developments
  13. 6.3 Changjiang Pharmaceutical
  14. 6.3.1 Changjiang Pharmaceutical Company Information
  15. 6.3.2 Changjiang Pharmaceutical Business Overview
  16. 6.3.3 Changjiang Pharmaceutical Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Changjiang Pharmaceutical Papaverine Injection Product Portfolio
  18. 6.3.5 Changjiang Pharmaceutical Recent Developments
  19. 6.4 Jiangsu Hengrui Pharmaceuticals
  20. 6.4.1 Jiangsu Hengrui Pharmaceuticals Company Information
  21. 6.4.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  22. 6.4.3 Jiangsu Hengrui Pharmaceuticals Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Pharmaceuticals Papaverine Injection Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  25. 6.5 Hunan Yige Pharmaceutical
  26. 6.5.1 Hunan Yige Pharmaceutical Company Information
  27. 6.5.2 Hunan Yige Pharmaceutical Business Overview
  28. 6.5.3 Hunan Yige Pharmaceutical Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hunan Yige Pharmaceutical Papaverine Injection Product Portfolio
  30. 6.5.5 Hunan Yige Pharmaceutical Recent Developments
  31. 6.6 Furen Pharmaceutical
  32. 6.6.1 Furen Pharmaceutical Company Information
  33. 6.6.2 Furen Pharmaceutical Business Overview
  34. 6.6.3 Furen Pharmaceutical Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Furen Pharmaceutical Papaverine Injection Product Portfolio
  36. 6.6.5 Furen Pharmaceutical Recent Developments
  37. 6.7 Northeast Pharmaceutical Group
  38. 6.7.1 Northeast Pharmaceutical Group Company Information
  39. 6.7.2 Northeast Pharmaceutical Group Business Overview
  40. 6.7.3 Northeast Pharmaceutical Group Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Northeast Pharmaceutical Group Papaverine Injection Product Portfolio
  42. 6.7.5 Northeast Pharmaceutical Group Recent Developments
  43. 6.8 Chengdu Brilliant Pharmaceutical
  44. 6.8.1 Chengdu Brilliant Pharmaceutical Company Information
  45. 6.8.2 Chengdu Brilliant Pharmaceutical Business Overview
  46. 6.8.3 Chengdu Brilliant Pharmaceutical Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chengdu Brilliant Pharmaceutical Papaverine Injection Product Portfolio
  48. 6.8.5 Chengdu Brilliant Pharmaceutical Recent Developments
  49. 6.9 Vulcan
  50. 6.9.1 Vulcan Company Information
  51. 6.9.2 Vulcan Business Overview
  52. 6.9.3 Vulcan Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vulcan Papaverine Injection Product Portfolio
  54. 6.9.5 Vulcan Recent Developments
  55. 6.10 SGPharma
  56. 6.10.1 SGPharma Company Information
  57. 6.10.2 SGPharma Business Overview
  58. 6.10.3 SGPharma Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SGPharma Papaverine Injection Product Portfolio
  60. 6.10.5 SGPharma Recent Developments
  61. 6.11 Oryza Pharmaceuticals
  62. 6.11.1 Oryza Pharmaceuticals Company Information
  63. 6.11.2 Oryza Pharmaceuticals Business Overview
  64. 6.11.3 Oryza Pharmaceuticals Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Oryza Pharmaceuticals Papaverine Injection Product Portfolio
  66. 6.11.5 Oryza Pharmaceuticals Recent Developments
  67. 6.12 Montage Laboratories
  68. 6.12.1 Montage Laboratories Company Information
  69. 6.12.2 Montage Laboratories Business Overview
  70. 6.12.3 Montage Laboratories Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Montage Laboratories Papaverine Injection Product Portfolio
  72. 6.12.5 Montage Laboratories Recent Developments
  73. 6.13 Mercury Laboratories
  74. 6.13.1 Mercury Laboratories Company Information
  75. 6.13.2 Mercury Laboratories Business Overview
  76. 6.13.3 Mercury Laboratories Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Mercury Laboratories Papaverine Injection Product Portfolio
  78. 6.13.5 Mercury Laboratories Recent Developments
  79. 6.14 Cipla
  80. 6.14.1 Cipla Company Information
  81. 6.14.2 Cipla Business Overview
  82. 6.14.3 Cipla Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cipla Papaverine Injection Product Portfolio
  84. 6.14.5 Cipla Recent Developments
  85. 6.15 Centurion Healthcare
  86. 6.15.1 Centurion Healthcare Company Information
  87. 6.15.2 Centurion Healthcare Business Overview
  88. 6.15.3 Centurion Healthcare Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Centurion Healthcare Papaverine Injection Product Portfolio
  90. 6.15.5 Centurion Healthcare Recent Developments
  91. 6.16 American Regent
  92. 6.16.1 American Regent Company Information
  93. 6.16.2 American Regent Business Overview
  94. 6.16.3 American Regent Papaverine Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 American Regent Papaverine Injection Product Portfolio
  96. 6.16.5 American Regent Recent Developments
7 North America by Country
  1. 7.1 North America Papaverine Injection Sales by Country
  2. 7.1.1 North America Papaverine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Papaverine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Papaverine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Papaverine Injection Market Size by Country
  6. 7.2.1 North America Papaverine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Papaverine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Papaverine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Papaverine Injection Sales by Country
  2. 8.1.1 Europe Papaverine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Papaverine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Papaverine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Papaverine Injection Market Size by Country
  6. 8.2.1 Europe Papaverine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Papaverine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Papaverine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Papaverine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Papaverine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Papaverine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Papaverine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Papaverine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Papaverine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Papaverine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Papaverine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Papaverine Injection Sales by Country
  2. 10.1.1 South America Papaverine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Papaverine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Papaverine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Papaverine Injection Market Size by Country
  6. 10.2.1 South America Papaverine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Papaverine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Papaverine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Papaverine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Papaverine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Papaverine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Papaverine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Papaverine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Papaverine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Papaverine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Papaverine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Papaverine Injection Value Chain Analysis
  2. 12.1.1 Papaverine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Papaverine Injection Production Mode & Process
  7. 12.2 Papaverine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Papaverine Injection Distributors
  10. 12.2.3 Papaverine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst